openPR Logo
Press release

Alzheimer's Disease Diagnostic Market Growing Trade among Emerging Economies Opening New Opportunities by 2027

๐€๐ฅ๐ณ๐ก๐ž๐ข๐ฆ๐ž๐ซ'๐ฌ ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐ƒ๐ข๐š๐ ๐ง๐จ๐ฌ๐ญ๐ข๐œ ๐Œ๐š๐ซ๐ค๐ž๐ญ

๐€๐ฅ๐ณ๐ก๐ž๐ข๐ฆ๐ž๐ซ'๐ฌ ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐ƒ๐ข๐š๐ ๐ง๐จ๐ฌ๐ญ๐ข๐œ ๐Œ๐š๐ซ๐ค๐ž๐ญ

๐€๐ฅ๐ณ๐ก๐ž๐ข๐ฆ๐ž๐ซ'๐ฌ ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐ƒ๐ข๐š๐ ๐ง๐จ๐ฌ๐ญ๐ข๐œ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐†๐ซ๐จ๐ฐ๐ญ๐ก ๐จ๐ซ ๐ƒ๐ž๐ฆ๐š๐ง๐ ๐ˆ๐ง๐œ๐ซ๐ž๐š๐ฌ๐ž ๐จ๐ซ ๐ƒ๐ž๐œ๐ซ๐ž๐š๐ฌ๐ž ๐Ÿ๐จ๐ซ ๐ฐ๐ก๐š๐ญ ๐œ๐จ๐ง๐ญ๐š๐ข๐ง๐ฌ :

The Alzheimer's disease diagnostic market is experiencing robust growth driven by the increasing prevalence of the disease, an aging global population, and rising awareness about early diagnosis. Advances in diagnostic technologies, including imaging techniques such as PET and MRI scans, as well as biomarker-based tests, are significantly enhancing the accuracy and early detection of Alzheimer's disease. Governments and healthcare organizations worldwide are investing heavily in research and development to improve diagnostic methods, which is further propelling market growth. Additionally, the development of non-invasive and more accessible diagnostic tools is making it easier for healthcare providers to identify the disease at its early stages, thereby improving patient outcomes.

The Alzheimer's disease diagnostic market is experiencing robust growth driven by the increasing prevalence of the disease, an aging global population, and rising awareness about early diagnosis. Advances in diagnostic technologies, including imaging techniques such as PET and MRI scans, as well as biomarker-based tests, are significantly enhancing the accuracy and early detection of Alzheimer's disease. Governments and healthcare organizations worldwide are investing heavily in research and development to improve diagnostic methods, which is further propelling market growth. Additionally, the development of non-invasive and more accessible diagnostic tools is making it easier for healthcare providers to identify the disease at its early stages, thereby improving patient outcomes.

๐€๐ฅ๐ณ๐ก๐ž๐ข๐ฆ๐ž๐ซ'๐ฌ ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐ƒ๐ข๐š๐ ๐ง๐จ๐ฌ๐ญ๐ข๐œ ๐‚๐€๐†๐‘ ๐„๐ฌ๐ญ๐ข๐ฆ๐š๐ญ๐ข๐จ๐ง:

The market for Alzheimer's disease diagnostics was estimated to be worth US$ 3.47 billion in 2023, and during the forecast period, total revenue is anticipated to expand at a rate of 12.8% from 2024 to 2030, or roughly US$ 8.07 billion.

๐„๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ž ๐š๐๐๐ข๐ญ๐ข๐จ๐ง๐š๐ฅ ๐๐ž๐ญ๐š๐ข๐ฅ๐ฌ ๐›๐ฒ ๐œ๐ฅ๐ข๐œ๐ค๐ข๐ง๐  ๐ญ๐ก๐ž ๐ฅ๐ข๐ง๐ค ๐ฉ๐ซ๐จ๐ฏ๐ข๐๐ž๐: https://www.maximizemarketresearch.com/request-sample/116921/

๐€๐ฅ๐ณ๐ก๐ž๐ข๐ฆ๐ž๐ซ'๐ฌ ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐ƒ๐ข๐š๐ ๐ง๐จ๐ฌ๐ญ๐ข๐œ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ๐š๐ญ๐ข๐จ๐ง:

๐›๐ฒ ๐’๐ฉ๐ž๐œ๐ข๐ฆ๐ž๐ง

Cholinesterase Inhibitors
NMDA Receptor Antagonist
Other

During the projected period, cholinesterase inhibitors are anticipated to account for the greatest market share. Prominent pharmacological activities, such as preventing the loss of mental function in dementia and Alzheimer's disease patients, are major factors contributing to the market's growth. Additionally, the level of cholinesterase can be utilized as a surrogate indicator of exposure to arsenic. Doctors prescribe cholinesterase inhibitors to treat symptoms pertaining to thinking, memory, language, judgment, and other stimulating processes or reactions. Furthermore, the US FDA has approved a number of medications for the treatment of Alzheimer's diseases, including Exelon, Aricept, and Razadyne, which are used to treat mild to moderate Alzheimer's disease.

๐›๐ฒ ๐ƒ๐ข๐š๐ ๐ง๐จ๐ฌ๐ญ๐ข๐œ๐ฌ

Brain Imaging
CFS Test for Alzheimer's Diseases

๐€๐ฅ๐ณ๐ก๐ž๐ข๐ฆ๐ž๐ซ'๐ฌ ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐ƒ๐ข๐š๐ ๐ง๐จ๐ฌ๐ญ๐ข๐œ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐Ž๐ฏ๐ž๐ซ๐ฏ๐ข๐ž๐ฐ:

The Alzheimer's disease diagnostic market encompasses a variety of tools and techniques used to identify and monitor the progression of Alzheimer's disease. This market includes imaging technologies such as positron emission tomography (PET) and magnetic resonance imaging (MRI), as well as cerebrospinal fluid (CSF) analysis and blood-based biomarker tests. The increasing prevalence of Alzheimer's disease, driven by an aging population, is a significant factor fueling market growth. Additionally, there is a strong emphasis on early diagnosis and intervention, which is critical for managing the disease and improving patient outcomes. Advances in diagnostic technologies, such as the development of non-invasive tests and the integration of artificial intelligence for enhanced accuracy, are further propelling the market. Supportive government initiatives and growing investment in research and development are also contributing to the expansion of the Alzheimer's disease diagnostic market.


๐„๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ž ๐š๐๐๐ข๐ญ๐ข๐จ๐ง๐š๐ฅ ๐๐ž๐ญ๐š๐ข๐ฅ๐ฌ ๐›๐ฒ ๐œ๐ฅ๐ข๐œ๐ค๐ข๐ง๐  ๐ญ๐ก๐ž ๐ฅ๐ข๐ง๐ค ๐ฉ๐ซ๐จ๐ฏ๐ข๐๐ž๐: https://www.maximizemarketresearch.com/request-sample/116921/

๐€๐ฅ๐ณ๐ก๐ž๐ข๐ฆ๐ž๐ซ'๐ฌ ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐ƒ๐ข๐š๐ ๐ง๐จ๐ฌ๐ญ๐ข๐œ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐†๐ซ๐จ๐ฐ๐ญ๐ก ๐จ๐ซ ๐ƒ๐ž๐ฆ๐š๐ง๐ ๐ข๐ง ๐ฐ๐ก๐ข๐œ๐ก ๐ซ๐ž๐ ๐ข๐จ๐ง๐ฌ??

The Alzheimer's disease diagnostic market is experiencing significant growth across various regions, with North America leading the way. The United States, in particular, dominates the market due to its advanced healthcare infrastructure, high awareness levels about Alzheimer's disease, and substantial investment in research and development. Government initiatives, such as the National Plan to Address Alzheimer's Disease, aim to improve diagnosis and care, further driving market growth. Additionally, the presence of major diagnostic companies and extensive clinical research activities contribute to the robust demand for Alzheimer's diagnostics in this region.

The Alzheimer's disease diagnostic market is experiencing significant growth across various regions, with North America leading the way. The United States, in particular, dominates the market due to its advanced healthcare infrastructure, high awareness levels about Alzheimer's disease, and substantial investment in research and development. Government initiatives, such as the National Plan to Address Alzheimer's Disease, aim to improve diagnosis and care, further driving market growth. Additionally, the presence of major diagnostic companies and extensive clinical research activities contribute to the robust demand for Alzheimer's diagnostics in this region.

๐€๐ฅ๐ณ๐ก๐ž๐ข๐ฆ๐ž๐ซ'๐ฌ ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐ƒ๐ข๐š๐ ๐ง๐จ๐ฌ๐ญ๐ข๐œ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐’๐œ๐จ๐ฉ๐ž ๐š๐ง๐ ๐Œ๐ž๐ญ๐ก๐จ๐๐จ๐ฅ๐จ๐ ๐ฒ:

The Alzheimer's disease diagnostic market encompasses a broad range of diagnostic tools and technologies aimed at early detection, monitoring, and progression assessment of Alzheimer's disease. This includes imaging techniques such as positron emission tomography (PET) and magnetic resonance imaging (MRI), as well as cerebrospinal fluid (CSF) analysis, blood-based biomarker tests, and neuropsychological testing. The market also covers advancements in non-invasive diagnostic methods and the integration of artificial intelligence (AI) and machine learning (ML) for improved diagnostic accuracy. The scope extends across various healthcare settings, including hospitals, diagnostic laboratories, and research institutes, with applications in early diagnosis, disease monitoring, and therapeutic response assessment.

๐…๐จ๐ซ ๐š ๐๐ž๐ž๐ฉ๐ž๐ซ ๐ฎ๐ง๐๐ž๐ซ๐ฌ๐ญ๐š๐ง๐๐ข๐ง๐ , ๐œ๐ฅ๐ข๐œ๐ค ๐จ๐ง ๐ญ๐ก๐ž ๐ฅ๐ข๐ง๐ค: https://www.maximizemarketresearch.com/request-sample/116921/

๐€๐ฅ๐ณ๐ก๐ž๐ข๐ฆ๐ž๐ซ'๐ฌ ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐ƒ๐ข๐š๐ ๐ง๐จ๐ฌ๐ญ๐ข๐œ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐Š๐ž๐ฒ ๐๐ฅ๐š๐ฒ๐ž๐ซ๐ฌ

1. Eli Lilly and Company
2. TauRx (Republic of Singapore)
3. Alector LLC
4. Accera, Inc.
5. Treventis Corporation
6. Neuro-Bio Ltd
7. Cognition Therapeutics Inc
8. Hoffmann-La Roche
9. Novartis AG
10. Merck & Co.

๐“๐จ ๐š๐œ๐œ๐ž๐ฌ๐ฌ ๐ฆ๐จ๐ซ๐ž ๐œ๐จ๐ฆ๐ฉ๐ซ๐ž๐ก๐ž๐ง๐ฌ๐ข๐ฏ๐ž ๐ข๐ง๐Ÿ๐จ๐ซ๐ฆ๐š๐ญ๐ข๐จ๐ง, ๐œ๐ฅ๐ข๐œ๐ค ๐ก๐ž๐ซ๐ž:https://www.maximizemarketresearch.com/market-report/global-alzheimers-disease-diagnostic-market/116921/

๐Š๐ž๐ฒ ๐ช๐ฎ๐ž๐ฌ๐ญ๐ข๐จ๐ง๐ฌ ๐š๐ง๐ฌ๐ฐ๐ž๐ซ๐ž๐ ๐ข๐ง ๐ญ๐ก๐ž ๐€๐ฅ๐ณ๐ก๐ž๐ข๐ฆ๐ž๐ซ'๐ฌ ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐ƒ๐ข๐š๐ ๐ง๐จ๐ฌ๐ญ๐ข๐œ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐š๐ซ๐ž:
โ€ข What is ๐€๐ฅ๐ณ๐ก๐ž๐ข๐ฆ๐ž๐ซ'๐ฌ ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐ƒ๐ข๐š๐ ๐ง๐จ๐ฌ๐ญ๐ข๐œMarket ?
โ€ข What is the growth rate of the ๐€๐ฅ๐ณ๐ก๐ž๐ข๐ฆ๐ž๐ซ'๐ฌ ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐ƒ๐ข๐š๐ ๐ง๐จ๐ฌ๐ญ๐ข๐œ Market?
โ€ข Which are the factors expected to drive the ๐€๐ฅ๐ณ๐ก๐ž๐ข๐ฆ๐ž๐ซ'๐ฌ ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐ƒ๐ข๐š๐ ๐ง๐จ๐ฌ๐ญ๐ข๐œ market growth?
โ€ข What are the different segments of the ๐€๐ฅ๐ณ๐ก๐ž๐ข๐ฆ๐ž๐ซ'๐ฌ ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐ƒ๐ข๐š๐ ๐ง๐จ๐ฌ๐ญ๐ข๐œ Market?
โ€ข What growth strategies are the players considering to increase their presence in ๐€๐ฅ๐ณ๐ก๐ž๐ข๐ฆ๐ž๐ซ'๐ฌ ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐ƒ๐ข๐š๐ ๐ง๐จ๐ฌ๐ญ๐ข๐œ?
โ€ข What are the upcoming industry applications and trends for the ๐€๐ฅ๐ณ๐ก๐ž๐ข๐ฆ๐ž๐ซ'๐ฌ ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐ƒ๐ข๐š๐ ๐ง๐จ๐ฌ๐ญ๐ข๐œ Market?
โ€ข What are the recent industry trends that can be implemented to generate additional revenue streams for the ๐€๐ฅ๐ณ๐ก๐ž๐ข๐ฆ๐ž๐ซ'๐ฌ ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐ƒ๐ข๐š๐ ๐ง๐จ๐ฌ๐ญ๐ข๐œ Market?
โ€ข What major challenges could the ๐€๐ฅ๐ณ๐ก๐ž๐ข๐ฆ๐ž๐ซ'๐ฌ ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐ƒ๐ข๐š๐ ๐ง๐จ๐ฌ๐ญ๐ข๐œ Market face in the future?
โ€ข What segments are covered in the ๐€๐ฅ๐ณ๐ก๐ž๐ข๐ฆ๐ž๐ซ'๐ฌ ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐ƒ๐ข๐š๐ ๐ง๐จ๐ฌ๐ญ๐ข๐œ Market?
โ€ข Who are the leading companies and what are their portfolios in ๐€๐ฅ๐ณ๐ก๐ž๐ข๐ฆ๐ž๐ซ'๐ฌ ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐ƒ๐ข๐š๐ ๐ง๐จ๐ฌ๐ญ๐ข๐œ Market?
โ€ข What segments are covered in the ๐€๐ฅ๐ณ๐ก๐ž๐ข๐ฆ๐ž๐ซ'๐ฌ ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐ƒ๐ข๐š๐ ๐ง๐จ๐ฌ๐ญ๐ข๐œ Market?
โ€ข Who are the key players in the ๐€๐ฅ๐ณ๐ก๐ž๐ข๐ฆ๐ž๐ซ'๐ฌ ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐ƒ๐ข๐š๐ ๐ง๐จ๐ฌ๐ญ๐ข๐œ market?

๐‘๐ž๐ฅ๐š๐ญ๐ž๐ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ:

โ™ฆ Global Eye Drops and Lubricants Market https://www.maximizemarketresearch.com/market-report/global-eye-drops-and-lubricants-market/55333/

โ™ฆ Global Linear Motor Market https://www.maximizemarketresearch.com/market-report/global-linear-motor-market/33915/

โ™ฆ global glass fiber reinforced concrete market https://www.maximizemarketresearch.com/market-report/global-glass-fiber-reinforced-concrete-market/69180/

โ™ฆ Global Sputtering Target Market https://www.maximizemarketresearch.com/market-report/global-sputtering-target-market/102381/

โ™ฆ G-Protein Coupled Receptors (GPCRs) Market https://www.maximizemarketresearch.com/market-report/global-g-protein-coupled-receptors-gpcrs-market/104389/

โ™ฆ Alcoholic Ice Cream Market https://www.maximizemarketresearch.com/market-report/global-alcoholic-ice-cream-market/96989/

โ™ฆ Agarwood Oil Market https://www.maximizemarketresearch.com/market-report/global-agarwood-oil-market/107023/

โ™ฆ Global Healthcare Consulting Service Market https://www.maximizemarketresearch.com/market-report/global-healthcare-consulting-service-market/17103/

โ™ฆ Acute Lung Injury Market https://www.maximizemarketresearch.com/market-report/acute-lung-injury-market/146138/

โ™ฆ Electric Enclosure Market https://www.maximizemarketresearch.com/market-report/electric-enclosure-market/2482/

๐‚๐จ๐ง๐ญ๐š๐œ๐ญ ๐Œ๐š๐ฑ๐ข๐ฆ๐ข๐ณ๐ž ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก:

3rd Floor, Navale IT Park, Phase 2
Pune Banglore Highway, Narhe,
Pune, Maharashtra 411041, India
sales@maximizemarketresearch.com
+91 96071 95908, +91 9607365656

๐€๐›๐จ๐ฎ๐ญ ๐Œ๐š๐ฑ๐ข๐ฆ๐ข๐ณ๐ž ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก:

Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Alzheimer's Disease Diagnostic Market Growing Trade among Emerging Economies Opening New Opportunities by 2027 here

News-ID: 3582390 • Views: โ€ฆ

More Releases from Maximize Market Research pvt. Ltd.

Indonesia Electric Vehicle Market Valued at US $533.19 Mn in 2022, Projected to Reach US $2020.13 Mn by 2029
Indonesia Electric Vehicle Market Valued at US $533.19 Mn in 2022, Projected to โ€ฆ
Indonesia Electric Vehicle Market was valued at US $ 533.19 Mn. in 2022. Indonesia Electric Vehicle Market size is estimated to grow at a CAGR of 20.96%. The market is expected to reach a value of US $ 2020.13 Mn. in 2029. Indonesia Electric Vehicle Market Overview: The Indonesia electric vehicle (EV) market is in a nascent but rapidly accelerating stage of development, strategically positioned to become a major hub in theโ€ฆ
Food E-Commerce Market Valued at USD 343.31 Billion in 2024, Poised for 20.3% CAGR Growth Through 2032
Food E-Commerce Market Valued at USD 343.31 Billion in 2024, Poised for 20.3% CA โ€ฆ
Food E-Commerce Market size was valued at USD 343.31 Billion in 2024 and the total Food E-Commerce revenue is expected to grow at a CAGR of 20.3% from 2025 to 2032, reaching nearly USD 1505.99 Billion. Food E-Commerce Market Overview: The food e-commerce market represents the digital transformation of grocery shopping, encompassing the online sale and delivery of food products, including fresh produce, pantry staples, prepared meals, and specialty items. This sectorโ€ฆ
Defense Electronics Market Valued at USD 200 Billion in 2023, Projected to Reach USD 287.10 Billion by 2030
Defense Electronics Market Valued at USD 200 Billion in 2023, Projected to Reach โ€ฆ
Defense Electronics Market size was valued at USD 200 Bn. in 2023 and the total revenue is expected to grow at a CAGR of 5.3 % from 2024 to 2030, reaching nearly USD 287.10 Bn. Defense Electronics Market Overview: The defense electronics market encompasses the specialized electronic systems and components integral to modern military operations. This sector includes critical technologies such as radar and sonar systems, electronic warfare (EW) capabilities, communications andโ€ฆ
Global Magnesium Alloys Market Poised to Grow from US$ 2.21 Billion in 2024 to US$ 5.58 Billion by 2032 at a CAGR of 12.25% - Magnesium Alloys Market Forecast
Global Magnesium Alloys Market Poised to Grow from US$ 2.21 Billion in 2024 to U โ€ฆ
According to a new report by Maximizer Market Research, the Global Magnesium Alloys Market was valued at USD 2.21 billion in 2024 and is projected to reach USD 5.58 billion by 2032, growing at a CAGR of 12.25%. This growth is underpinned by rising demand from automotive & transportation, electronics, aerospace, defense, and medical industries seeking lightweight, high-performance materials. For full access to the data, request a sample report now :https://www.maximizemarketresearch.com/request-sample/32753/ โ™ฆโ€ฆ

All 5 Releases


More Releases for Alzheimer

Dementia - Alzheimer Disease Market: A Comprehensive Analysis 2030
Dementia and Alzheimer's disease represent significant challenges within the global healthcare sector. These neurological disorders, characterized by progressive cognitive decline, have seen increasing prevalence due to aging populations worldwide. This growing burden has spurred interest in the Dementia - Alzheimer's disease market, encompassing diagnostic tools, treatments, caregiving solutions, and related healthcare services. This article provides an overview of the market, its scope, current trends, and factors driving its expansion. Data Bridgeโ€ฆ
Alzheimer Disease Treatment Market | Allergan, Amgen, Daiichi Sankyo, Eisai
The global alzheimer disease treatment market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the alzheimer disease treatment market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants. From the perspective of market dynamics, this report explores the factors driving the growthโ€ฆ
United States Alzheimer Drugs Market Insights Deep Analysis 2023-2031
Cognate Life Sciences introduces a report on "United States Alzheimer Drugs Market 2023" with Market Insights Reports, Introduces systematic details in terms of market valuation, market size, revenue estimation, and geographical spectrum of the business vertical. The study also talks about crucial pockets of the industry such as products or services offered, downstream fields, end using customers, historic data figures regarding revenue and sales, market context and more. It conjointlyโ€ฆ
Global Alzheimer Market, Global Alzheimer Industry, Covid-19 Impact Global Alzhe โ€ฆ
Alzheimer's is a progressive disease that leads to the death of brain cells, resulting in memory loss, behavioral issues, and disruption the thought processes. The Alzheimer disease is considered fatal. Age and heredity are the two main risk factors for developing Alzheimer's disease. Several other preventable risk factors have been associated to the development of this disease, including diet, environment, and overall general health. A combination of risk factors isโ€ฆ
US Alzheimer Drug Pipeline Analysis
In US, the Alzheimer's disease is the 6th leading cause of death overall and among those aged 65 and above, it is the 5th leading cause of death. While the deaths from major diseases, like heart disease have decreased, the death due to Alzheimer's have increased by more than 60% between 2000 and 2012. The total number of patients having Alzheimerโ€™s disease was 5.4 million in 2012. Out of this,โ€ฆ
Global Alzheimer Market Report: 2015 Edition | Now Available at Researchmoz.us
Researchmoz added Most up-to-date research on "Global Alzheimer Market Report: 2015 Edition" to its huge collection of research reports. Alzheimerโ€™s disease is defined as an advanced neurological disorder that increasingly deprives patients of their memory and ability to carry out daily activities. As it grows in a human brain, individuals are likely to practice difficulties in linguistic, agility and insight along with negative changes in the character and performance such asโ€ฆ